These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8549373)

  • 1. Antimicrobial activity, pharmacokinetics and clinical studies of balofloxacin (Q-35) in obstetrics and gynaecology.
    Cho N; Miyakawa Z; Kimura T; Shimizu A; Notake Y; Kunii K
    Drugs; 1995; 49 Suppl 2():391-2. PubMed ID: 8549373
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical study of T-3761 in obstetrics and gynaecology.
    Matsuda S
    Drugs; 1995; 49 Suppl 2():393-4. PubMed ID: 8549374
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with OPC-17116 in the treatment of gynaecological infections and its penetration into gynaecological tissues. Japanese Collaborative Study Group of OPC-17116 in Gynaecology.
    Matsuda S
    Drugs; 1995; 49 Suppl 2():395-8. PubMed ID: 8549375
    [No Abstract]   [Full Text] [Related]  

  • 4. NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
    Mikamo H; Kawazoe K; Izumi K; Ito K; Tamaya T
    Drugs; 1995; 49 Suppl 2():326-30. PubMed ID: 8549350
    [No Abstract]   [Full Text] [Related]  

  • 5. [The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].
    Padeĭskaia EN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(2):30-9. PubMed ID: 9551171
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental and clinical studies of temafloxacin in the field of obstetrics and gynecology].
    Matsuda S; Shimizu T; Cho N; Okada H
    Jpn J Antibiot; 1993 Jun; 46(6):492-504. PubMed ID: 8395608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
    [No Abstract]   [Full Text] [Related]  

  • 8. The antimicrobial activity of sparfloxacin, a new quinolone.
    Paradelis AG; Delidou K; Grigoriadou A; Salpigides G; Pangalis A
    Drugs; 1995; 49 Suppl 2():238-9. PubMed ID: 8549316
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory and clinical study of balofloxacin (Q-35), a new fluoroquinolone, in urinary tract infection.
    Suzuki K; Horiba M; Ishikawa K; Katoh S; Naide Y; Yanaoka M; Andoh S
    Drugs; 1995; 49 Suppl 2():376-8. PubMed ID: 8549367
    [No Abstract]   [Full Text] [Related]  

  • 10. Sparfloxacin and other new fluoroquinolones.
    Richard P; Gutmann L
    J Antimicrob Chemother; 1992 Dec; 30(6):739-44. PubMed ID: 1337749
    [No Abstract]   [Full Text] [Related]  

  • 11. ESGAB breakpoint determination: temafloxacin.
    Phillips I; Acar J; Baquero F; Bergan T; Forsgren A; Wiedemann B
    Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):991-2. PubMed ID: 1665417
    [No Abstract]   [Full Text] [Related]  

  • 12. [New fluoroquinolones and treatment of acute sinusitis].
    Gehanno P; Trémolières F
    Presse Med; 1999 Sep; 28(25):1365. PubMed ID: 10506868
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections].
    Iakovlev SV
    Urologiia; 2002; (1):11-4. PubMed ID: 11877963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant gram-positive human pathogens.
    Zerva L; Marshall SA; Jones RN
    J Antimicrob Chemother; 1996 Oct; 38(4):742-4. PubMed ID: 8937972
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.
    Wolfson JS; Hooper DC
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1655-61. PubMed ID: 2686545
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro activity of the active metabolite of prulifloxacin (AF 3013) compared with six other fluoroquinolones.
    Prats G; Roig C; Miró E; Navarro F; Mirelis B
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):328-34. PubMed ID: 12072950
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence of resistance to fluoroquinolones among bacteria causing infections in food animals in Denmark.
    Aarestrup FM; Jensen NE; Jorsal SE; Nielsen TK
    Vet Rec; 2000 Jan; 146(3):76-8. PubMed ID: 10674696
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo antibacterial activities of Q-35, a novel fluoroquinolone.
    Iwasaki H; Miyazaki S; Tsuji A; Yamaguchi K; Goto S
    Chemotherapy; 1995; 41(2):100-12. PubMed ID: 7758353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.